The findings that PNPase is a regulator of persistence in this study and a target of tuberculosis persister drug PZA (12, 13) suggest that PNPase in different bacteria could be a promising new drug target for developing novel persister drugs for the improved treatment of persistent bacterial infections. Here, PNPT1 is linked to tuberculosis.